About StoryMD
StoryMD combines medical records, lab results and wearable data into a personal health narrative with AI-generated, round-the-clock insights. Users own and control their information. Its visual health library explains more than 6,500 conditions through plain language and illustrations. The platform serves patients and families, along with healthcare providers, foundations and pharmaceutical companies. Its iPad and iPhone app is StoryMD Health, and setup takes about five minutes.
Founder and CEO Alexander Tsiaras built StoryMD from three decades of medical visualization work. His earlier work appeared on Nature and Time covers and involved scientists at DARPA, NASA, Yale and the National Institutes of Health. The coded library has more than 400,000 visual assets created from real human data and mapped to medical-record codes. Foundation partnerships give patients free access through pharma-funded disease programs. StoryMD also supports clinical care and post-approval pharmaceutical intelligence. Its video journeys cover fertility, pregnancy, menopause, breast cancer and ovarian cancer, with more body areas planned. The company is based in Brooklyn, New York.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 22, 2026 | Nov 6, 2026 | $300,000of $2.0M target | 2 | $150K | EquityRule 506(b) | Form D ↗ |
| Jul 21, 2024 | Aug 5, 2024 | $492,000of $2.0M target | 3 | $164K | EquityRule 506(b) | Form D ↗ |
| May 19, 2023 | Jun 15, 2023amended Oct 23, 2023 | $165,000of $3.5M target | 3 | $55,000 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 24, 2021 | Mar 11, 2021amended Mar 13, 2023 | $4,000,108of $6.5M target | 27 | $148K | EquityRule 506(b) | Form D/A ↗3 earlier filings |
| Jul 30, 2020 | Aug 12, 2020 | $350,000of $1.2M target | 2 | $175K | EquityRule 506(b) | Form D ↗ |
| Feb 7, 2020 | Feb 24, 2020 | $100,000of $1.0M target | 1 | $100K | EquityRule 506(b) | Form D ↗ |
| Feb 27, 2018 | Mar 13, 2018 | $1,350,000of $2.5M target | 6 | $225K | EquityRule 506(b) | Form D ↗ |
| Jul 27, 2017 | Aug 11, 2017 | $300,000of $500K target | 3 | $100K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, eight offerings | $7,057,108 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Rounds announced by StoryMD
What the company said publicly about its funding. Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.
| Announced | Round | Amount | Investors | Source |
|---|
Why Investors Backed StoryMD
StoryMD sells a personal health platform for patients, families and care organizations. Its visual library uses the same medical codes as patient records. The company also applies the platform to clinical care and drug companies studying therapies after approval.
The problem it targets
StoryMD addresses the confusion created by dense reports and disconnected patient portals. The idea followed a cancer diagnosis affecting someone close to Alexander Tsiaras. That person received hard-to-read reports and had to use several separate portals. Tsiaras wanted health data to tell a story that patients could understand.
What the product does
Medical records, laboratory results and wearable data feed a continuously updated health narrative. AI supplies personalized insights around the clock. Plain-language explanations and visuals help people with different health literacy and education levels. The visuals come from human data rather than stock art.
We wrote this summary from public statements by StoryMD and its investors. It is not investment advice.
StoryMD in the News
Leadership Team
Executive officers and directors listed on StoryMD's Form D filed Nov 6, 2026.